Repository logo
Communities & Collections
All of MSAR
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Haggag, Yusuf"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Fucoidans as nanoparticles: pharmaceutical and biomedical applications
    (Elsevier, 14/01/2022) Zayed, Ahmed; Haggag, Yusuf; Ezzat, Shahira M; Salem, Mohamed A; Ulber, Roland
    Fucoidans are multifunctional marine sulfated polysaccharides. They have gained much interest in the last few decades, due to promising and diverse biological activities. Additionally, nanobiotechnology is a relatively new scientific field, which has been developed to improve the quality of life, including medicine. Formulation of fucoidans in nanoparticles has taken different forms owing to their polyanionic and reducing nature. They are used in either plain preparations or as a capping agent for various metal nanoparticles or in combination with other cationic polymers as a drug carrier. These applications have resulted in increasing the medical efficiency of fucoidans, opening new era in drug delivery systems for anticancers and antibiotics and helping diagnosis of human diseases as well. The current chapter deals with different aspects regarding technologies used for fucoidans nanoparticles synthesis and utilization of such formulations specifically in the fields of nanomedicine.

October University for Modern Sciences and Arts Established by Dr. Nawal El Degwi in 1996 copyright © 2019-2024

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback